The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): ##STR00001## pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.